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Disease-related malnutrition in adult patients who have been admitted to hospital is a 
syndrome associated with substantially increased morbidity, disability, short-term and long-
term mortality, impaired recovery from illness, and cost of care. There is uncertainty 
regarding optimal diagnostic criteria, definitions for malnutrition, and how to identify 
patients who would benefit from nutritional intervention. Malnutrition has become the 
focus of research aimed at translating current knowledge of its pathophysiology into 
improved diagnosis and treatment. Researchers are particularly interested in developing 
nutritional interventions that reverse the negative effects of disease-related malnutrition in 
the hospital setting. High-quality randomised trials have provided evidence that nutritional 
therapy can reduce morbidity and other complications associated with malnutrition in some 
patients. Screening of patients for risk of malnutrition at hospital admission, followed by 
nutritional assessment and individualised nutritional interventions for malnourished 





Malnutrition indiscriminately affects individuals at all stages of life, from infants and 
children to adolescents and older adults. According to WHO,1 malnutrition refers to 
deficiencies, excesses, or imbalances in a person's intake of energy or nutrients and includes 
three groups of conditions—namely, undernutrition (eg, wasting, stunting, and 
underweight), micronutrient-related malnutrition (eg, iron deficiency anaemia, vitamin A 
deficiency, and iodine deficiency disorders), and overweight (eg, obesity and non-
communicable diseases that are diet related). Although undernutrition and micronutrient 
deficiencies were once associated with low-income and middle-income countries, and 
overnutrition with high-income countries, many parts of the world now have all of these 
malnutrition-related problems. With advances in medical treatment and the rising number 
of patients who are older than 65 years and have multiple morbidities, disease-related 
malnutrition in patients with multiple illnesses has become a growing concern. 
 
Data from the USA and Europe show that up to a third of patients in hospital have 
malnutrition or are at risk of malnutrition at the time of hospital admission.2-6 Additionally, a 
patient's nutritional status often deteriorates during their hospital stay due to illness-related 
loss of appetite, drug-related side-effects, fasting orders for diagnostic studies, diseases that 
impair the normal functioning of the digestive system, overall suboptimal management of 
inpatient nutrition, and disease-related and disuse-related wasting. Patients sometimes feel 
that poor appetite is to be expected during treatment in hospital and both patients and 
medical staff can believe that medical treatment is the main priority and that food is of 
secondary importance.7 
 
Malnutrition has been historically defined as insufficient intake or uptake of nutrition that 
leads to altered body composition (loss of fat-free mass) and body-cell mass, which, in turn, 
causes decreased physical and mental function and impaired clinical outcome.8 Yet, this 
definition of malnutrition is only one of several found in the literature, leaving considerable 
scope for confusion and misunderstanding.9, 10 Disease-related malnutrition is a complex 
syndrome resulting from inadequate intake of nutrients that does not fulfil the patient's 
physiological requirement and from disease-related systemic inflammatory response. The 
absence of simple and unequivocal diagnostic criteria that have high specificity and 
sensitivity for malnutrition has been an obstacle to consensus. In addition, most diagnostic 
criteria for malnutrition were validated with regard to their use in predicting adverse clinical 
outcomes, such as morbidity and mortality, rather than predicting which patients might 
respond to nutritional therapy. Nevertheless, progress has been made in defining disease-
related malnutrition and global experts have now proposed a framework to help in the 
diagnosis of malnutrition.8 New diagnostic criteria for malnutrition, applied to patients who 
are medically or surgically unwell, include alterations in body composition that result from 
an inflammatory response.11-14 Thus, the main drivers for disease-related malnutrition can 
be from inflammation-driven or undernutrition-driven catabolism. 
 
There is a strong association between malnutrition and increased risk of adverse clinical 
outcomes, which include higher rates of morbidity and mortality, functional decline, and 
prolonged hospital stays.3, 15 Associations between malnutrition and adverse clinical 
outcomes are largely independent of the underlying medical condition.3, 5 We, and other 
researchers, have concluded that early recognition of malnutrition at hospital admission 
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through active nutritional screening, nutritional assessment, and adequate treatment are 
important elements of patient care in medical wards.16 Fortunately, the specialty concerned 
with nutrition for inpatients with medical conditions has advanced substantially. Historically, 
evidence encouraging nutritional interventions was inadequate and relied mainly on 
observational research.17 However, several trials studying the role of nutritional therapy for 
patients being treated in hospital have changed the understanding of the management of 
malnutrition and have identified malnutrition as an important target for intervention.18 
This Review provides an up-to-date view of current approaches to best identify and manage 
disease-related malnutrition in adult patients who are being treated for medical conditions 
(ie, not having surgical treatment) in the hospital setting. Approaches include patient 
screening for the risk of malnutrition at hospital admission, nutritional assessment and 
application of diagnostic criteria for malnutrition, evidence-based nutritional algorithms to 
provide best nutritional care for individual patients, selection of patients most likely to 
benefit from nutritional interventions, and nutritional considerations after discharge from 
hospital. 
Search strategy and selection criteria 
We searched MEDLINE with the terms “disease-related malnutrition”, “malnutrition”, and 
“malnourished”, in combination with one or more of the terms “pathogenesis”, 
“pathophysiology”, “diagnosis”, “screening”, “assessment”, “treatment”, “nutrition(al) 
support”, “nutrition(al) intervention”, “hospital”, and “inpatient”, for articles published 
from Jan 1, 2011, to Jan 6, 2021. We identified the articles on adult medical inpatient 
populations and selected the most relevant clinical trials, systematic reviews, and high-
quality review articles. Studies of critically ill or surgical patients were excluded. We also 
manually searched reference lists of identified articles to retrieve additional studies. 
Pathogenesis 
Malnutrition can result from one or a combination of the following factors: starvation, 
disease (eg, polypharmacy, disease-related inflammatory mechanisms, and compromised 
intake or assimilation of nutrients), immobility-associated muscle wasting,19 and older age 
or social isolation.20 Although the pathogenesis of disease-related malnutrition is complex in 
general, acute and chronic inflammation have been found to be key contributing factors to 
reduced appetite with a decrease in intake of energy and protein. Endocrine changes also 
lead to catabolism, fatigue, and immobilisation (figure 1).21 Cytokines, such as IL 
(interleukin)-6 and tumour necrosis factor α (TNFα), affect brain circuits that control food 
intake, delay gastric emptying, and influence skeletal muscle catabolism. Acute and chronic 
illnesses also impact various endocrine systems, resulting in catabolism (eg, increase 
in cortisol concentrations, down-regulation of sex hormones, and peripheral growth 
hormone resistance). Cytokines modulate the hypothalamic–pituitary–adrenal axis response 
and stimulate the release of stress hormones, including cortisol and catecholamines, which, 
in turn, increase muscle catabolism.22, 23 Incretin hormones (such as glucagon-like peptide-1 
[GLP-1; pro-glucagon]), which are released directly from gut tissues, also affect malnutrition. 
There is evidence of interaction between inflammatory cytokines (mainly IL-6 and IL-1β) and 
GLP-1 (and its analogues) that resulted in reduced food intake and unintentional weight 
loss.24 Finally, illness-related factors, such as gastrointestinal dysfunction, logistics of care, 
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and concerns about feed-related complications, such as aspiration for enteral nutrition and 
sepsis for parenteral nutrition, can lead to chronic underfeeding.25 Patients admitted to 
hospital have the additional burden of acute illness, inflammation, immobilisation, and 





Figure 1. Pathophysiology of malnutrition 
IL=interleukin. TNFα=tumour necrosis factor α. 
Screening tools for the hospital setting 
Malnutrition is diagnosed in a phased approach. The first phase consists of nutritional 
screening to identify patients who are at risk of malnutrition. Professional societies 
recommend screening for malnutrition within the first 24–48 h of hospital admission, and at 
regular intervals thereafter, to rapidly and accurately identify individuals who need to be 
referred to a specialist for nutritional assessment and possible intervention.26 Various 
malnutrition screening tools exist to detect potential or manifested malnutrition during 
admission of a patient to hospital.18, 27 Screening and assessment tools need to be easy to 
use in clinical practice, require minimal training of personnel, and be broadly applicable to 
all patients being admitted to hospital. However, a detailed nutritional assessment requires 
skilled nutrition specialists to establish if a patient has, or is at risk of, malnutrition and the 
extent and causes of it. 
 
As the majority of screening components have little sensitivity and specificity when used 
independently, screening tools that identify patients who are at risk of developing 
malnutrition require inclusion of several parameters. High levels of validity, agreement, and 
reliability in malnutrition screening tools are desirable to ensure correct identification 
(without under-referrals or over-referrals) and the prompt treatment of patients who are 
malnourished. For the selection of the appropriate screening tool, it is important to 
understand whether the tool was validated for the patient population (eg, age and medical 
condition) and setting of interest (eg, hospital, institutional, or community setting). Table 
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1 provides details of effective screening and assessment tools for adults, including an 
overview of their validity, agreement, and reliability.27-33 
 
Table 1. Characteristics of major nutrition screening and assessment tools for adults 
 









Weight loss; reduced food 
intake in the past week; BMI; 
impaired general condition; 
severity of disease; and age 
Nutritional risk (≥3 
points) and no 
nutritional risk (<3 
points) 










Weight loss; BMI; and reduced 
food intake for ≥5 days (acute 
disease) 
Low risk of 
malnutrition; 
medium risk of 
malnutrition; and 
high risk of 
malnutrition 
Adults outside of 
hospital and adults 
admitted to 









Reduced food intake during the 
past 3 months; weight loss 
during the past 3 months; 
mobility; psychological stress 
or acute disease; 
neuropsychological problems; 
and BMI or calf circumference 
Normal nutritional 
status; at risk of 
malnutrition; and 
malnourished 
Older adults living 
in institutional 
settings and older 








Weight loss and reduced food 
intake 
Low risk of 
malnutrition; 
medium risk of 
malnutrition; and 
high risk of 
malnutrition 
Older adults living 
in institutional 










Weight loss; decreased 
appetite; and use of 
















Weight loss; reduced food 
intake; gastrointestinal 
symptoms; functional capacity; 
comorbid illness and its 
relation to nutritional 








Adults admitted to 
hospital and adults 






*Validity, agreement, and reliability according to Skipper and colleagues.33 
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Diagnostic criteria for disease-related malnutrition and nutritional assessment 
The second step in the diagnostic pathway is to apply specific criteria to substantiate the 
diagnosis of malnutrition in patients admitted to hospital. The Global Leadership Initiative 
on Malnutrition (GLIM) has published the most recent of these specific criteria.12, 13 GLIM 
proposes a straightforward two-step approach to diagnosis of disease-related malnutrition, 
with an initial screening to identify patients who are at risk that is followed by a more in-
depth assessment to diagnose malnutrition and grade its severity (figure 2).12, 13 Although 
several methods have been proposed in the past,15 GLIM was designed to provide a more 
specific diagnosis of malnutrition and includes three phenotypic criteria (unintentional 
weight loss, low body-mass index [BMI], and reduced muscle mass) and two aetiological 
criteria (reduced food intake or assimilation and increased inflammation or disease burden). 
On the basis of the GLIM criteria, at least one phenotypic criterion and one aetiological 
criterion must be present to reach a diagnosis of malnutrition. Phenotypic metrics for 
grading severity (stage 1 [moderate] and stage 2 [severe] malnutrition) have been 
proposed. GLIM recommend that the aetiological criteria be used to guide intervention and 
anticipate outcomes. The GLIM criteria support classification of malnutrition into four 
aetiology-related diagnosis categories (figure 2). 
 
During the diagnostic process, it would be ideal to distinguish malnourishment from other 
descriptive syndromes, such as sarcopenia, cachexia, and frailty. Although reduced muscle 
mass is a criterion for malnutrition in all current diagnostic criteria, it is also the hallmark 
feature of other descriptive syndromes. Cachexia refers to severe weight loss and wasting 
associated with cancer, HIV, and other severe illnesses. Although there are similarities 
between definitions of cachexia and malnutrition, inflammation and cytokines seem to be 
key components of cachexia, whereas malnutrition includes these components and 
starvation-related phenomena.34, 35 Frailty refers to poor homoeostasis after an acute illness 
and is a consequence of the cumulative decline in many physiological systems.36 
Phenotypically, frailty is often associated with unintentional weight loss, self-reported 
exhaustion, muscle weakness, slow walking speed, and low physical activity,8 but can also 
be viewed as the longer-term effect of malnutrition or cachexia. Some experts have 
suggested that malnutrition is the higher-order taxonomical term and that cachexia, 
sarcopenia, and frailty are different subtypes of the same condition.8 However, it is 
controversial whether these different syndromes are variations of the same common 
condition and need a common approach to diagnosis and treatment, or whether they are 
truly different disorders that merit distinct treatment strategies. 
 
Although the criteria proposed by GLIM are new, the content, criteria, and predictive 
validities of this tool have been assessed in many cohorts worldwide and, hopefully, they 
will become part of routine clinical practice for diagnosing malnutrition in a consistent 
manner.12, 13 However, there is still a need for prospective validation of these criteria in 
different patient populations and disease states, and the response to nutritional therapy in 
patients diagnosed as malnourished with the GLIM criteria is not known. Hence, GLIM is 
considered an evolving concept. The proponents of GLIM recognise this and plan re-





Figure 2. Current approach to screening and diagnosis 
Approach to screening is according to NRS-200227 and diagnosis is according to GLIM.12, 13 
BIA=bioelectrical impedance analysis. BMI=body-mass index. DXA=dual-energy x-ray 
absorptiometry. GLIM=Global Leadership Initiative on Malnutrition. NRS=Nutritional Risk 
Screening. 
 
This proposed approach, screening for the risk of malnutrition that is followed by 
establishment of the diagnosis, should be complemented with a more detailed nutritional 
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assessment to provide the foundation for individualised nutrition care plans. A nutritional 
assessment can comprehensively and objectively evaluate nutritional status. Nutritional 
assessment can include a dietary history (eg, food recall, food frequency questionnaires, 
and digital imaging technology to monitor food intake),38 physical examinations (eg, signs of 
severe subcutaneous loss, muscle wasting, and oedema), anthropometric measurements 
(eg, weight, height, BMI, mid-arm or calf circumference, and skinfold thickness), functional 
tests (eg, handgrip strength),39 functional status or independence (eg, Barthel index),40 body 
composition (eg, bioelectrical impedance analysis, dual-energy x-ray absorptiometry, CT, 
MRI, and isotope dilution methods), quality-of-life questionnaires, and laboratory values 
(eg, haemoglobin, C-reactive protein, albumin and prealbumin protein [transthyretin], 
creatinine, ferritin, zinc, vitamin [folate, vitamin B12, and vitamin D], and urea and 
electrolyte concentrations). The presence of a skilled nutritional specialist to interpret 
information obtained from the assessment is imperative. Accurate interpretation will result 
in more individualised and, thus, more effective nutritional intervention and monitoring. 
Nutritional interventions to improve clinical outcomes in the hospital setting 
The association of malnutrition with increased risks for adverse clinical outcomes and 
mortality has been well documented in several observational studies.3, 5, 15 However, the 
findings of several randomised controlled trials have sparked a new debate on best 
nutritional care practices in the hospital setting. Evidence of the benefits of nutritional 
interventions for medical inpatients is compelling. A systematic review and meta-analysis on 
nutritional therapy in inpatients with medical conditions found significantly improved 
clinical outcomes in those receiving adequate nutritional therapy compared with those 
receiving no nutritional therapy.41 The review included 27 randomised controlled trials from 
several countries comprising 6803 inpatients and reported a 27% reduction in mortality and 
non-elective hospital readmissions.41 Yet, there was some heterogeneity among trials and 
several studies (particularly the oldest ones) were at high risk for bias. In addition, wide 
variations in the treatment of control group patients were observed, reflecting differences 
in standards for what is considered usual practice for nutritional care. 
 
Table 2 provides a summary of the six most recent trials (published since 2015) on 
nutritional therapy for patients who are malnourished or at risk of malnutrition and were 
admitted to hospital.42-47 The largest trial included in table 2 was EFFORT, which was a 
pragmatic, randomised controlled multicentre trial in Switzerland and included more than 
2000 patients at risk of malnutrition (Nutritional Risk Screening total score of ≥3).43 EFFORT 
analysed the effects of individualised nutritional therapy, which aimed to reach energy, 
protein, and micronutrient requirements, compared with standard hospital food. The 
primary composite endpoint of the trial was severe complications, mortality, admission to 
the intensive care unit, cardiovascular and gastrointestinal complications, functional decline, 
and hospital readmission. In this trial, nutritional intervention was effective in lowering the 
risk of mortality with a number needed to treat of 37 patients.43 A similar positive effect on 
the risk of mortality (number needed to treat of 20 patients) was also found in the second-
largest, placebo-controlled trial, NOURISH.47 NOURISH compared the use of specialised 
protein-rich oral supplements with placebo on clinical outcomes in 652 patients from 
multiple centres across the USA. Although the trial was negative regarding its primary 
composite endpoint (90 day post-discharge incidence of death or non-elective readmission 
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to hospital), there was a significant reduction in 90 day mortality in the group given protein-
rich oral supplements. Studies in specific medical populations also exist. In a trial, which 
studied nutritional intervention for patients admitted to hospital for acute heart failure, the 
nutritional intervention group had reduced rates of mortality and repeat admission to 
hospital compared with the standard-of-care group.46 Another study that included patients 
with pneumonia in hospital found that nutritional intervention lowered the risk for disease-
specific readmission rates,42 but did not significantly improve mortality. Similarly, in two 
smaller trials,44, 45 patients given individualised nutrition plans did not have a significant 
reduction in mortality but did have a shorter length of hospital stay than patients given 
standard care. 
 
Although these trials had different approaches to nutritional intervention, they did share 
concepts. First, most trials initially screened admitted patients for the risk of malnutrition, 
which was followed by a thorough assessment of nutritional status by multidisciplinary 
teams (including dietitians, nurses, and physicians) to identify patients with disease-related 
malnutrition who might benefit from nutritional therapy. A detailed clinical assessment is 
important to identify side-effects of medications and medical illnesses, such as 
gastrointestinal and metabolic conditions, which can cause loss of appetite, difficulties in 
feeding, or malabsorption. Once a diagnosis of disease-related malnutrition has been 
established, guidelines recommend defining individual nutritional goals, including energy 
and protein intake, micronutrient intake, and other disease-specific targets.2, 48 Energy 
expenditure, on which most nutritional interventions are based, can be estimated 
with indirect calorimetry or a validated formula (eg, adapted Harris–Benedict 
equation).49 Validated formulae consider the resting metabolic rate and effects of any 
disease. In everyday clinical practice, simple weight-based formulas (eg, 25–30 kcal/kg of 
bodyweight per day) have also been valuable in estimating energy requirements.2 A high 
protein intake of 1·2–1·5 g/kg per day has been shown to improve clinical outcomes in adult 
patients (≥18 years) who are treated in hospital for medical conditions,43, 47 except in those 
with kidney failure, in which lower targets of 0·8 g/kg per day were used in one 
trial.43 However, the definition of optimal protein targets for patients with chronic kidney 
disease still needs additional research.48 Some procedures (eg, dialysis and paracentesis) 
can remove proteins from the body and these losses should also be included in the total 
daily protein requirements. According to consensus guidelines, multivitamin and 
multimineral supplements are also important adjuncts to correct micronutrient 
deficiencies.2, 48 Once energy requirements are estimated, a nutritional plan to reach these 
requirements should be established (preferably with the help of a dietitian) with an initial 
adoption of an oral diet plan (eg, meals selected according to patient preferences, food 
fortification, snacks, and oral nutritional supplements).48 If energy and protein targets 
cannot be reached orally, nutritional therapy should be escalated to enteral or parenteral 
feeding. Regular monitoring is essential to adjust the nutritional protocol. Figure 3 shows a 
pragmatic treatment algorithm for malnutrition in the inpatient setting that is based on a 





Table 2. Overview of six nutritional trials with medical inpatients  
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BMI=body-mass index. MNA=Mini Nutritional Assessment. MNA-SF=Mini Nutritional Assessment-Short Form. NRS=Nutritional Risk Screening. OR=odds ratio. PG-





Figure 3. Treatment algorithm for hospitalised patients at risk of malnutrition 
BMI=body-mass index. GLP-1=glucagon-like peptide-1 (pro-glucagon). MUST=Malnutrition 
Universal Screening Tool. NRS=Nutritional Risk Screening. SGLT2=sodium-glucose 
cotransporter-2. 
The considerations in figure 3, regarding initiating nutritional therapy during the hospital 
stay of medical inpatients, identified by screening and assessment, are in line with evidence-
based clinical practice guidelines regarding the nutritional approach for patients with 
multimorbid conditions,2 and older adult patients,50 from the European Society for Clinical 
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Nutrition and Metabolism (ESPEN) and the American Society for Parenteral and Enteral 
Nutrition (ASPEN).51 
 
Although there is wide consensus about the beneficial effects of energy and protein to 
reach nutritional goals in patients who are malnourished, the role of specific formulas 
enriched with fibre, immunonutrients (eg, omega-3 fatty acids, arginine, glutamine, RNA, 
and nucleotides), or other nutrients has not been well studied in medical inpatients.2 The 
NOURISH trial found clinical benefits of high-protein oral nutrition supplementation 
containing β-hydroxy β-methylbutyrate compared with placebo.47 However, it is unclear 
whether the maintenance of muscle mass during hospital stay and significant decrease in 
post-discharge mortality observed in this study were due to the specific product, the high 
levels of protein, the micronutrients provided by the supplement used in the intervention 
group, or any combination of these. 
Refeeding syndrome 
Although nutritional therapy is generally considered safe with low risk for complications, 
particular attention to refeeding syndrome is important. Refeeding syndrome is a life-
threatening metabolic complication that is caused by rapid feeding in combination with 
inadequate provision of micronutrients and electrolytes (eg, phosphate, potassium, 
magnesium, and vitamin B1). Refeeding syndrome can occur with oral, enteral, 
or parenteral nutrition52 and it is often not recognised and, therefore, not treated 
appropriately.53 Oral and enteral nutrition has a higher risk of refeeding syndrome than 
parenteral nutrition due to the incretin effect.54 In one nutritional trial in patients fed orally, 
parenterally, or via the nasogastric route, 15% of patients had refeeding syndrome, which 
was associated with increased 180 day mortality rates, 180 day intensive care unit 
admission rates, and length of hospital stay.55 In one consensus paper, diagnostic criteria for 
imminent refeeding syndrome have been defined as a decrease in electrolyte 
concentrations—eg, a >30% decrease from baseline or an absolute value of ≤0·6 mmol/L of 
phosphate concentration, or any other electrolyte (eg, magnesium or potassium) below the 
normal range—within 72 h of starting nutritional therapy.56 In addition, manifest refeeding 
syndrome is considered if any electrolyte shifts occur in combination with typical clinical 
symptoms (eg, oedema, tachycardia, and tachypnoea).56 An ASPEN interprofessional 
taskforce defined refeeding syndrome with a formulation similar to the one listed in the 
consensus paper,56 the main difference being that no distinction was made between 
imminent and manifest clinical situations.57 Risk assessment, establishment of a care plan, 
and monitoring of patients throughout nutritional therapy are important to reduce 
refeeding syndrome-related morbidity. The UK National Institute for Health and Care 
Excellence criteria (low BMI; substantial unintentional weight loss; insufficient nutritional 
intake; low concentrations of potassium, phosphate, or magnesium before feeding; or a 
history of alcohol or drug use, including insulin, chemotherapy, antacids, or diuretics) are 
helpful for identification of patients at high risk of refeeding syndrome, with starvation 
being the predominant risk factor.58 Unless plasma concentrations of electrolytes are high, 
patients at risk of refeeding syndrome should receive generous prophylactic provision of 
electrolytes (eg, 2–4 mmol/kg per day of potassium, 0·3–0·6 mmol/kg per day of phosphate, 
and 0·2–0·4 mmol/kg per day of magnesium).58 In a patient who has been starved, plasma 
electrolyte concentrations do not reflect whole body status and there could be a substantial 
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intracellular depletion, particularly as 98% of potassium is intracellular.52, 58, 59 Additionally, 
patients should receive vitamin B1, 200–300 mg/day) and multivitamin supplements 
immediately before and during the first 10 days of feeding.58 In patients at risk of refeeding 
syndrome, excess sodium and fluid can also be dangerous, and an intake of less than 1 
mmol/kg per day of sodium and 20 mL/kg per day of fluid is recommended in the early 
phase of refeeding.52, 59 Nutritional therapy should be started with reduced energy goals and 
increased slowly to the full caloric requirements during 5–10 days, according to the 
individual risk classification of refeeding syndrome.56 Electrolyte concentrations should be 
monitored daily during the period that the patient is suspectable to refeeding syndrome, 
alongside additional clinical examination with special attention to hydration status and 
parameters to detect signs and symptoms of fluid overload or micronutrients deficiency. 
Personalised nutrition and malnutrition biomarkers during treatment in hospital 
Understanding the pathophysiology of malnutrition is key to developing effective new 
interventions. Translational research in the pathophysiology of malnutrition is expanding 
rapidly. Although there is currently a strong consensus that nutritional protocols should be 
individualised regarding nutritional targets for inpatients (based on their BMI and severity of 
illness) in critical care and hospital ward settings, current research suggests that 
tailoring nutrition to the specific medical illness of patients could also improve the 
effectiveness of nutritional intervention. This concept of personalised nutrition is based on 
the observation that not all patients show the same response to nutritional interventions. 
Whether or not a patient benefits from nutritional therapy might relate to illness-specific 
factors (eg, comorbidities, inflammation, and acute vs chronic course) or patient-specific 
factors (eg, age and genetic vulnerability). Biomarkers and key predictors of these factors 
might improve the individualised approach when treating a patient with malnutrition. 
Several effect-modifying conditions and parameters have been proposed and tested 
empirically (table 3).39, 42, 46, 60-69 Currently, the acuteness of the disease and systemic 
inflammation (the key driver of disease-related reduction in appetite), reduced food intake, 
and muscle catabolism seem to predict the response to nutritional treatment.69-71 In a 
secondary analysis of EFFORT, stratification for C-reactive protein concentration at 
admission showed that patients with high levels of inflammation (C-reactive protein >100 
mg/L) did not have decreased mortality when receiving individualised nutrition therapy 
compared with patients who did not receive individualised nutrition, a finding that was 
significant in interaction analyses.69 This result could explain the differences in clinical 
results depending on the clinical setting—namely, the absence of a response to 
individualised nutrition in studies done in patients who have critical illness or advanced 
cancer. It is not known whether low-grade inflammation, typically seen in patients with 
obesity or diabetes, also needs attention. Another modifying condition is chronic kidney 
disease, as patients with reduced kidney function showed a stronger response to nutritional 
treatment than those with healthy kidney function.43 
 
Despite these findings, specific blood biomarkers of malnutrition are not yet available in 
routine clinical care. Research in this area is complex due to differing views of the definition 
of malnutrition, the absence of a strong reference definition, the existence of several 
pathophysiological pathways, and the influence of underlying clinical illnesses 
and multimorbidity on nutrition markers.72 For example, despite being used as markers in 
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the past, albumin and prealbumin concentrations are now recognised to be strongly 
influenced by disease-related factors such as inflammation, liver function, fluid balance, and 
metabolism. Despite being highly predictive of morbidity and mortality, they do not reflect 
the adequacy of nourishment.73 A position paper from ASPEN highlights that, although there 
is an association between inflammation and malnutrition, there is no association between 
malnourishment and visceral-protein concentrations.74 As such, serum albumin and 
prealbumin should not be used as surrogate measures of total body protein, total muscle 
mass, or status of nourishment, but can provide prognostic information, such as disease-
related muscle wasting in the absence of starvation.73 
 
Table 3. Potential effect-modifying factors regarding personalised nutritional therapy 
in patients treated in hospital on medical wards 
 




High prevalence of 
malnutrition; elevated 
cytokine concentrations and 
inflammation causing loss of 
appetite; and intestinal 
oedema leading to 
malabsorption (cardiac 
cachexia) 
RCTs with a small sample 




colleagues46 showed reduced all-
cause mortality rate and reduced 
readmission rates; a meta-
analysis60 showed that patients given 
personalised nutritional therapy had 
increased bodyweight; and a 
secondary analysis of an 
RCT61 showed reduced mortality and 
major cardiovascular events 
Cancer 
High prevalence of 
malnutrition; cytokine-driven 
systemic inflammation 
leading to reduction in 
appetite and food intake; 
muscle loss (tumour 
cachexia); and side-effects of 
tumour therapy 
Meta-analyses of several 
trials from the outpatient 
setting; tumour-specific 
or therapy-specific trials; 
and a retrospective 
propensity score-
matched analysis 
A meta-analysis62 showed the 
positive effect of personalised 
nutritional therapy on nutritional 
intake and quality of life, but not on 
mortality; a meta-analysis63showed 
an increase of bodyweight in 
patients receiving 
chemoradiotherapy; an 
RCT64 showed the positive effect on 
long-term outcomes in patients with 
colorectal carcinoma who are having 
radiotherapy. A large propensity 
score-matched retrospective 
analysis,65 with different cancer 
types, showed lower risk of in-
hospital mortality and discharge to a 
post-acute care facility for inpatient 
care in a heterogeneous cancer 
population than without nutritional 
therapy; and a secondary analysis of 
an RCT66 showed lower mortality in 
patients with different types of 









High risk for malnutrition; 
accumulation of nitrogen-
containing products from 
dietary and intrinsic protein 
catabolism negatively affects 
appetite and taste; uraemia 
reducing gastrointestinal 
nutrient absorption; and 
side-effects of medication 
Insufficient evidence for 
the treatment of 
malnutrition from a 
secondary analysis; 
protein intake goals are 
controversial because of 
recommendations of 
protein restriction 
A secondary analysis of an RCT67 with 
medical inpatients at nutritional risk 
showed kidney function at admission 
was a strong predictor for the 




Malnutrition is frequent in 
patients with lower 
respiratory tract infection 
Some evidence from an 
RCT with a small sample 
size and secondary 
analysis; high-quality 
evidence is sparse for 
patients with COVID-19 
who are not critically ill 
An RCT42 showed nutritional therapy 
reduced readmission rates for 
pneumonia; and a secondary analysis 
of an RCT68 showed a positive effect 
on 30 day mortality 
Strength and muscle function 
Handgrip 
strength 
Handgrip strength is an easy-
to-use tool to assess muscle 
strength in clinical practice 
and is endorsed by 
numerous international 
clinical nutrition guidelines 
due to the known association 
of low handgrip strength 
with poor clinical outcomes Insufficient evidence 
A secondary analysis of an 
RT39 showed that patients with low 






Often considered as 
nutritional markers 
No evidence regarding 
predictive value for 





Inflammation often has a 
role in the 
pathophysiological 
mechanisms of malnutrition; 
inflammation leads to insulin 
resistance and reduction of 
appetite 
Evidence from secondary 
analysis that is similar to 
results from trials in 
intensive care units 
A secondary analysis of an 
RCT69 showed no effect of nutritional 
therapy in patients with high C-
reactive protein concentrations 
RCT=randomised controlled trial. 
 
Knowledge about the role of the gut microbiota on several aspects of health has also been 
increasing in the past years. A new microbiota-directed supplement has been shown to 
effectively treat malnutrition in children in low-income settings, leading to improved growth 
and weight gain.75 Additional research will be needed to establish whether these promising 
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results from children who are malnourished in low-income settings can be extrapolated to 
adults who are malnourished as inpatients. 
Long-term nutritional therapy after hospital discharge 
In the long term, patients with malnutrition have a high risk of disease-related mortality. 
Meta-analyses of trials in patients who have been discharged from hospital showed 
beneficial effects of ongoing nutritional therapy with regards to energy and protein 
intake and bodyweight, but no effect on mortality.76-78 A long-term follow-up study of 
patients in the EFFORT trial reported a substantial increase in 5 year mortality risk related 
to nutrition risk score, increasing from approximately 50% to approximately 60%, with 
Nutritional Risk Screening-2002 score increasing from 3 to 5.79 Nevertheless, the effects of 
nutritional therapy that was stopped at hospital discharge did not show a legacy effect after 
6 months.79 Yet, several trials (such as the NOURISH trial) that offered continued nutritional 
therapy in the outpatient setting after discharge from hospital have reported significant 
beneficial effects of nutritional therapy on mortality over time.46, 47, 80 Thus, there is 
evidence to support the continuation of individualised nutritional therapy after discharge 
from hospital for patients with existing risk of (or manifested) malnutrition. However, 
additional research is needed to support this hypothesis in an adequately powered trial. 
Ethical considerations 
Although nutritional interventions are recommended for most patients who need them, 
guidelines advise that special considerations should be given to patients without capacity 
and those on palliative care.81, 82 The important ethical principles in the doctor–patient 
relationship, including autonomy (principle of self-determination and recognition of the 
patient's rights), beneficence (the view that the patient should be provided with some form 
of benefit), non-maleficence (the deliberate avoidance of harm), and justice (the fair and 
equitable provision of available medical resources to all) should guide the decision-making 
process and there should be clear communication between the treating team, patient, and 
caregivers. Advance directives and proxies should be taken into consideration and 
discussions should be had about the potential futility of treatment and the net benefit to 
the patient before starting or stopping artificial nutritional therapy. Legal advice or court 
orders might have to be sought when there is disagreement between the treating team and 
the patient or their caregivers.81, 82 
 
The provision of food or water by mouth is generally considered part of basic care, which 
includes procedures deemed essential for patient comfort. Health-care professionals are 
duty-bound to ensure the provision of basic care to all patients, unless actively resisted by 
the patient.82 Therefore, voluntary cessation of eating and drinking is ethically acceptable if 
done on the basis of a competent patient's wishes or advance directives. 
Outlook and future considerations 
The optimal use of individualised nutritional therapy to effectively prevent and treat 
malnutrition is complex and constitutes a major area of current research. Specifically, the 
ideal time to initiate nutritional therapy in the hospital setting and the optimal duration 
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have not been well established. There is consensus that prevention of malnutrition is better 
than treatment, as data show that patients with advanced cachexia can have minimal 
response to nutritional treatment. Additionally, as patients with malnutrition have a 
substantial long-term risk of mortality and morbidity, there is great interest in researching 
long-term nutritional therapy that happens after discharge from hospital. A better 
understanding of the phenotypes of malnutrition is also needed to develop more 
personalised approaches in the future. A first step to the optimal use of nutritional therapy 
would be to better distinguish between malnutrition (ie, a multi-cause syndrome) and being 
malnourished (ie, a patient that received inadequate feeding). Because the underlying 
condition can predict the response to nutritional treatment, a patient with malnutrition due 
to inadequate feeding might need a different nutritional approach regarding the quantity 
and quality of feeding to a patient who is wasted from disease or in a state of severe 
inflammation. Although high protein and energy diets improve outcomes in patients who 
are medically stable, the same diet can cause hyperglycaemia and overfeeding in a patient 
who is metabolically stressed and critically ill, where modest provision of nutrients might be 
beneficial.83, 84 Importantly, to advance the field, large-scale interventional trials are needed 
with thorough phenotyping of participants to study the predictors of response to nutritional 
therapy, which can later be used to arrive at personalised treatment decisions. For example, 
the EFFORT trial43 has provided evidence that patients with chronic kidney disease have a 
more pronounced benefit from nutritional therapy than patients without chronic kidney 
disease67 and that the same treatment in patients with high levels of inflammation did not 
influence clinical outcomes in medical inpatients.69 Similarly, handgrip strength has been 
shown to be a predictor of response to nutritional therapy.39 Understanding these factors 
will help change the general guideline recommendation approach to more individualised 
nutritional therapy for patients with malnutrition. In addition to advancing the science of 
medical nutrition, there needs to be a focus on improving the education of students and 
health professionals on all aspects of nutritional care.85 Patients and their caregivers should 
be involved in the shared decision-making process before the start of nutritional therapy 
and this discussion should revolve around the BRAN concept (defined as understanding the 
benefits and risks of the interventions, considering alternative therapy, and knowing the 
consequences of doing nothing).86 Fully informed patients who have been involved in 
shared decision making are best equipped to assume responsibility and be partners in their 
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